A systematic review of the combined use of electroconvulsive therapy and psychotherapy for depression

Journal of ECT

Volumn 27, Issue 3, 2011, Pages 236-243

  McClintock, Shawn M ^a,b   Brandon, Anna R ^a   Husain, Mustafa M ^a   Jarrett, Robin B ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

cognitive behavior therapy; Electroconvulsive therapy; interpersonal psychotherapy; major depressive disorder; psychotherapy

Indexed keywords

DEPRESSION; ELECTROCONVULSIVE THERAPY; ELECTROSTIMULATION; GROUP THERAPY; HUMAN; MAJOR DEPRESSION; META ANALYSIS; PSYCHIATRIC TREATMENT; PSYCHOTHERAPY; REGRESSIVE ELECTROSHOCK TREATMENT; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; COGNITION DISORDERS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; HUMANS; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 80052460308     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3181faaeca     Document Type: Review

References (80)

1. American Psychiatric Association Task Force on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. Washington, DC: American Psychiatric Association; 2001.
2. Fink M, Taylor MA. Electroconvulsive therapy: evidence and challenges. JAMA. 2007;298(3):330-332.
3. Daly JJ, Prudic J, Devanand DP, et al. ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disorders. 2001;3:95-104. (Pubitemid 32492597)
4. Husain MM, Rush A, Fink M, et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a consortium for research in ECT (CORE) report. J Clin Psychiatry. 2004;65(4):485-491.
5. Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med. 2007;357:1939-1945. (Pubitemid 350074688)
6. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285(10):1299-1307. (Pubitemid 32216144)
7. Prudic JM, Sackeim HA, Rifas S. Medication resistance, response to ECT, and prevention of relapse. Psychiatric Annals. 1994;24(5):228-231.
8. Nobler MS, Sackeim HA. Augmentation strategies in electroconvulsive therapy: a synthesis. Convulsive Ther. 1993;9(4):331-351. (Pubitemid 24018323)
9. Sackeim HA, Dillingham EM, Prudic J, et al. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Arch Gen Psychiatry. 2009;66(7):729-737.
10. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression. Arch Gen Psychiatry. 2006;63(12):1337-1344.
11. Lisanby SH, Sampson S, Husain MM, et al. Toward individualized post-electroconvulsive therapy care: piloting the symptom-titrated, algorithm-based longitudinal (STABLE) intervention. J ECT. 2008;24(3):179-182.
12. Thase ME, Friedman ES, Biggs MM, et al. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry. 2007;164(5):739-752. (Pubitemid 46808529)
13. Beck AT, Rush AJ, Shaw BF, et al. Cognitive Therapy of Depression. New York, NY: The Guilford Press; 1979.
14. Klerman GL, Weissman MM. New Applications of Interpersonal Psychotherapy. Washington, DC: American Psychiatric Press; 1993.
15. Klerman GL, Weissman MM, Rounsaville BJ, et al. Interpersonal Psychotherapy of Depression. New York, NY: Basic Books; 1984.
16. Dunner DL, Blier P, Keller MB, et al. Preventing recurrent depression: long-term treatment for major depressive disorder. J Clin Psychiatry. 2007;68(4):619-630. (Pubitemid 46663047)
17. Jarrett RB, Vittengl JR, Clark LA. How much cognitive therapy, for which patients, will prevent depressive relapse? Jf Affect Disord. 2008;111:185-192.
18. Jarrett RB, Kraft D, Doyle J, et al. Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial. Arch Gen Psychiatry. 2001;58(4):381-388. (Pubitemid 32299534)
19. Fava GA, Ruini C, Rafanelli C, et al. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry. 2004;161(10):1872-1876. (Pubitemid 39314682)
20. Vittengl JR, Clark LA, Jarrett RB. Continuation-phase cognitive therapy's effects on remission and recovery from depression. J Consult Clin Psychol. 2009;77(2):367-371.
21. Kashner TM, Henley SS, Golden RM, et al. Assessing the preventive effects of cognitive therapy following relief of depression: a methodological innovation. J Affect Disord. 2007;104(1-3):251-261. (Pubitemid 350052328)
22. Vittengl JR, Clark LA, Dunn TW, et al. Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. J Consult Clin Psychol. 2007;75(3):475-488. (Pubitemid 47444751)
23. Schramm E, Schneider D, Zobel I, et al. Efficacy of interpersonal psychotherapy plus pharmacotherapy in chronically depressed inpatients. J Affect Disord. 2008;109(1-2):65-73.
24. Frank E, Kupfer DJ, Buysse DJ, et al. Randomized trial of weekly, twice-monthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression. Am J Psychiatry. 2007;164(5):761-767. (Pubitemid 46808531)
25. Hollon SD, Jarrett RB, Nierenberg AA, et al. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry. 2005;66(4):455-468. (Pubitemid 40593574)
26. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005;62(4):409-416. (Pubitemid 40471690)
27. Hollon SD, DeRubeis RJ, Shelton RC, et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry. 2005;62(4):417-422. (Pubitemid 40471691)
28. Marcus ER, Bradley SS. Combination of psychotherapy and psychopharmacotherapy with treatment-resistant inpatients with dual diagnoses. Psychiatr Clin North Am. 1990;13(2):209-214. (Pubitemid 20219991)
29. Arnow BA, Constantino MJ. Effectiveness of psychotherapy and combination treatment for chronic depression. J Clin Psychol. 2003;59(8):893-905. (Pubitemid 36897395)
30. Evans MD, Hollon SD, DeRubeis RJ, et al. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry. 1992;49(10):802-808.
31. Nobler MS, Oquendo MA, Kegeles LS, et al. Decreased regional brain metabolism after ECT. Am J Psychiatry. 2001;158(2):305-308. (Pubitemid 32116530)
32. Mayberg HS. Defining neurocircuits in depression: strategies toward treatment selection based on neuroimaging phenotypes. Psychiatric Annals. 2006;36(4):259-268.
33. Beck AT. The evolution of the cognitive model of depression and its neurobiological correlates. Am J Psychiatry. 2008;165:969-977.
34. Goldapple K, Segal Z, Garson C, et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry. 2004;61(1):34-41. (Pubitemid 38044639)
35. Brody AL, Saxena S, Stoessel P, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.[see comment]. Arch Gen Psychiatry. 2001;58(7):631-640. (Pubitemid 32640857)
36. Sanacora G, Fenton LR, Fasula MK, et al. Cortical [gamma]-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy. Biol Psychiatry. 2006;59(3):284-286. (Pubitemid 43208976)
37. Fenton L, Fasula M, Ostroff R, et al. Can cognitive behavioral therapy reduce relapse rates of depression after ECT? A preliminary study. J ECT. 2006;22(3):196-198. (Pubitemid 44379375)
38. Sackeim HA, Prudic J, Fuller R, et al. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2007;32(1):244-254. (Pubitemid 44967804)
39. Carey TS, Melvin CL, Ranney LM. Extracting key messages from systematic reviews. J Psychiatr Pract. 2008;14(suppl 1):28-34.
40. Milligan WL. Psychoneuroses treated with electrical convulsions. Lancet. 1946;2:516-520.
41. Glueck BC, Reiss H, Bernard LE. Regressive electric shock therapy. Psychiatric Q. 1957;31:119-136.
42. Bonn EM, Boorstein S. Regressive electroshock therapy and anaclitic psychotherapy. Electroshock and psychotherapy. Bull Menninger Clin. 1959;23:190-201.
43. Jaffe J, Esecover H, Kahn RL, et al. Modification of psychotherapeutic transactions by altered brain function. Am J Psychother. 1961;15:46-55.
44. Cohen R. EST + group therapy = improved care. Am J Nurs. 1971;71(6):1195-1198.
45. Thase ME, Friedman ES. Is psychotherapy an effective treatment for melancholia and other severe depressive states? J Affect Disord. 1999;54:1-19. (Pubitemid 29287668)
46. Yuuki N, Ida I, Oshima A, et al. HPA axis normalization, estimated by DEX/CRH test, but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures. Acta Psychiatr Scand. 2005;112(4):257-265. (Pubitemid 41382731)
47. Hickie I, Parsonage B, Parker G. Prediction of response to electroconvulsive therapy. Preliminary validation of a sign-based typology. Br J Psychiatry. 1990;157:65-71. (Pubitemid 20208662)
48. Husain MM, McClintock SM, Rush AJ, et al. The efficacy of acute electroconvulsive therapy in atypical depression. J Clin Psychiatry. 2008;69:406-411. (Pubitemid 351549393)
49. Jarrett RB, Schaffer M, McIntire D, et al. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56(5):431-437. (Pubitemid 29215432)
50. Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17(4):244-253. (Pubitemid 33131305)
51. Jackson C, Trower P, Reid I, et al. Improving psychological adjustment following a first episode of psychosis: a randomized controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy. 2009;47(6):454-462.
52. Garety PA, Fowler DG, Freeman D, et al. Cognitive-behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomized controlled trial. Br J Psychiatry. 2008;192(6):412-423. (Pubitemid 351809893)
53. Garety PA, Kuipers L, Fowler D, et al. Cognitive behavioural therapy for drug-resistant psychosis. Br J Med Psychol. 1994;67:259-271. (Pubitemid 24292315)
54. Conradi HJ, de Jonge P, Ormel J. Cognitive-behavioural therapy vs. usual care in recurrent depression. Br J Psychiatry. 2008;193(6): 505-506.
55. Lynch D, Laws KR, McKenna PJ. Cognitive behavioural therapy for major psychiatric disorders: does it really work? A meta-analytical review of well-controlled trials. Psychol Med. 2010;40:9-24.
56. Watkins E, Scott J, Wingrove J, et al. Rumination-focused cognitive behaviour therapy for residual depression: a case series. Behav Res Ther. 2007;45(9):2144-2154. (Pubitemid 47210940)
57. Kellner CH, Fink M, Knapp R, et al. Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. Am J Psychiatry. 2005;162(5):977-982. (Pubitemid 40676212)
58. Stellrecht NE, Gordon KH, Van Orden K, et al. Clinical applications of the interpersonal-psychological theory of attempted and completed suicides. J Clin Psychol. 2006;62(2):211-222. (Pubitemid 43242599)
59. Coleman D, Casey JT. Therapeutic mechanisms of suicidal ideation: the influence of changes in automatic thoughts and immature defenses. Crisis: The Journal of Intervention and Suicide Prevention. 2007;28(4):198-203.
60. Heisel MJ, Duberstein PR, Talbot NL, et al. Adapting interpersonal psychotherapy for older adults at risk for suicide: preliminary findings. Professional Psychology: Research and Practice. 2009;40(2): 156-164.
61. Squire LR, Chace PM. Memory functions six to nine months after electroconvulsive therapy. Convuls Ther. 1996;12(4):240-256.
62. Fraser LM, O'Carroll RE, Ebmeier KP. The effect of electroconvulsive therapy on autobiographical memory: a systematic review. J ECT. 2008;24(1):10-17. (Pubitemid 351498636)
63. Prudic J. Strategies to minimize cognitive side effects with ECT: aspects of ECT technique. J ECT. 2008;24(1):46-51. (Pubitemid 351498642)
64. Loo C, Sheehan P, Pigot M, et al. A report on mood and cognitive outcomes with right unilateral ultrabrief pulsewidth (0.3 ms) ECT and retrospective comparison with standard pulsewidth right unilateral ECT. J Affect Disord. 2007;103(1-3):277-281. (Pubitemid 47445782)
65. Sackeim HA, Prudic J, Nobler MS, et al. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimulation. 2008;1(2):71-83. (Pubitemid 351698629)
66. Sienaert P, Vansteelandt K, Demyttenaere K, et al. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: cognitive side-effects. J Affect Disord. 2010;122(1-2):60-67.
67. Overholser JC. Cognitive-behavioral treatment of depression: a three-stage model to guide treatment planning. Cognitive and Behavioral Practice. 2003;10:231-239. (Pubitemid 38281787)
68. Dozois DJA, Dobson KS. A longitudinal investigation of information processing and cognitive organization in clinical depression: stability of schematic interconnectedness. J Consult Clin Psychol. 2001;69(6):914-925. (Pubitemid 33140493)
69. Hollon SD, Stewart MO, Strunk D. Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety. Annu Rev Psychol. 2006;57:285-315. (Pubitemid 43237234)
70. Post F. Psychotherapy, electro-convulsive treatments, and long-term management of elderly depressives. J Affect Disord. 1985;8(suppl 1): S41YS45. (Pubitemid 16125636)
71. Shelton RC. Long-term management of depression: tips for adjusting the treatment plan as the patient's needs change. J Clin Psychiatry. 2009;70(suppl 6):32-37.
72. Folstein MF, Folstein SE, Fanjiang G. MMSE: Mini-Mental State Examination Clinical Guide, Lutz, FL: Psychological Assessment Resources, Inc; 2001.
73. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699. (Pubitemid 41623495)
74. Rush AJ, Kraemer HC, Sackeim HA, et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31:1841-1853.
75. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: response, remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48:851-855.
76. Weiss AP, Guidi J, Fava M. Closing the efficacy-effectiveness gap: translating both the what and the how from randomized controlled trials to clinical practice. J Clin Psychiatry. 2009;70(4):446-449.
77. Fava GA, Park SK, Sonino N. Treatment of recurrent depression. Expert Rev Neurother. 2006;6(11):1735-1740. (Pubitemid 44904017)
78. Petersen TJ. Enhancing the efficacy of antidepressants with psychotherapy. J Psychopharmacol. 2006;20(suppl 3):19-28. (Pubitemid 44605929)
79. Insel TR. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch Gen Psychiatry. 2009;66(2):128-133.
80. Abse DW, Ewing JA. Transference and countertransference in somatic therapies. J Nerv Ment Dis. 1956;123(1):32-40.